Global Information
회사소개 | 문의 | 위시리스트

서방성 주사제

Sustained Release Injectables to 2026

리서치사 Greystone Research Associates
발행일 2019년 08월 상품 코드 672887
페이지 정보 영문
가격
US $ 3,850 ₩ 4,646,000 PDF by E-mail (Single User License)
US $ 5,500 ₩ 6,638,000 PDF by E-mail (Site License)
US $ 7,500 ₩ 9,052,000 PDF by E-mail (Corporate License)


서방성 주사제 Sustained Release Injectables to 2026
발행일 : 2019년 08월 페이지 정보 : 영문

서방성 주사제(Sustained Release Injectables)에 대해 조사 분석했으며, 출시 제품, 제제 기술, 수요 촉진요인, 시장 잠재성과 과제, 치료제 시장 부문, 시장 영향요인 등의 정보를 전해드립니다.

주요 요약

주사제 시장 역학

  • 자기 투여 동향
  • 주사제의 제제 기술
  • 주사용 기기 설계의 혁신
  • 치료 수요 촉진요인
  • 시장요인
  • 경쟁 상황
  • 위험인자

서방성 제제 기술

  • 생분해성 고분자
  • SR 제제 기술의 브랜드화
  • 물리적 프로세스 관리 방법

서방성 주사제 : 개발요인

  • 제제요인
  • 안정성
  • 동결건조
  • 패키징
  • 투여요인

서방성 제품 상황

  • 알칼로이드
  • 마취제
  • 항종양약
  • GnRH 작용제
  • 오피오이드 길항제
  • 합성 펩티드
  • 사이토카인
  • 호르몬
  • 항정신병약
  • 기타

개발 단계 SR 주사제

SR 주사제 : 치료제 시장 부문 분석과 예측

  • 중독
  • 내분비학
  • 혈당관리
  • 감염증
  • 호르몬결핍증
  • 대사질환
  • 신경학
  • 종양학
  • 백혈병
  • 림프종
  • 전립선
  • 통증관리
  • 생식건강

기업 개요

KSM 18.08.20

이 페이지에 게재되어 있는 내용은 최신판과 약간 차이가 있을 수 있으므로 영문목차를 함께 참조하여 주시기 바랍니다. 기타 자세한 사항은 문의 바랍니다.

Currently approved sustained release injectables rely on a spectrum of branded formulation technologies to modulate the drug's release profile post-injection. Typically off-patent or generic drugs, they include drug therapies for almost a dozen major therapeutic segments, including neurological conditions, metabolic diseases, oncology, pain management and reproductive health. As the incidence and prevalence of chronic illnesses increases with the aging population, the attraction and interest in sustained release injectables will increase.

Sustained Release Injectables - What You Will Learn

  • What are the marketed sustained release injectable drug products, what sustained release formulation technologies are used, and who markets them?
  • What are the major factors driving sustained release injectable drug demand?
  • What sustained release injectable drug candidates are in late-stage clinical development and what is their potential impact?
  • How important are drug developer-formulation technologist relationships in the sustained release market segment, and what are the key alliances in the industry?
  • What are the essential formulation factors, delivery device selection issues, related technology factors and market development issues for sustained release injectable drug products?
  • In what therapeutic market segments do sustained release injectables compete? What is their market share today? What will it be in 2022? What is their expected growth rate?
  • What are the significant economic, technology, and regulatory factors affecting the market for sustained release injectables?

Table of Contents

Executive Summary

Injectable Drug Market Dynamics

  • The Trend toward Self-Administration
  • Injectable Drug Formulation Technology
  • Innovation in Injectable Device Designs
  • Therapeutic Demand Drivers
  • Market Factors
  • Competitive Landscape
  • Risk Factors

Sustained Release Formulation Technologies

  • Biodegradable Polymers
  • Branded SR Formulation Technologies
  • Physical Process Control Methods

Sustained Release Injectables - Development Factors

  • Formulation Factors
  • Stability
  • Lyophilization
  • Packaging
  • Administration Factors

The Sustained Release Product Landscape

  • Alkaloids
  • Anesthetics
  • Antineoplastics
  • GnRH Agonists
  • Opioid Antagonists
  • Synthetic Peptides
  • Cytokines
  • Hormones
  • Antipsychotics
  • Other Drug Classes

Development-stage SR Injectables

SR Injectables - Therapeutic Market Sector Analysis & Forecasts

  • Addiction
  • Endocrinology
  • Glycemic Control
  • Infectious Disease
  • Hormone Deficiency
  • Metabolic Diseases
  • Neurology
  • Oncology
  • Leukemia
  • Lymphoma
  • Prostate
  • Pain Management
  • Reproductive Health

Company Profiles

Back to Top
전화 문의
F A Q